Investment
Features
FeesSafety
Academy
More
Pluang+

Boyaa Interactive buys 115 more Bitcoin, now holding 4,316 BTC, ranking 22nd globally among public firms.

Market News
07 Sep 2026
Crypto Briefing
View Source
Bullish
Boyaa Interactive buys 115 more Bitcoin, now holding 4,316 BTC, ranking 22nd globally among public firms.

Boyaa Interactive, a Hong Kong-listed gaming company, purchased an additional 115 Bitcoin, increasing its total holdings to approximately 4,316 BTC. This move places Boyaa as the 22nd largest public company Bitcoin holder worldwide. The company acquired about 205 BTC between late June and early September 2026, spending around $14.3 million from idle operational cash, avoiding debt or share issuance. Unlike many corporate holders, Boyaa actively uses its Bitcoin, staking 1,000 BTC in its blockchain project, showing a strategic approach to cryptocurrency as part of its treasury management.

More News

Applied Digital eyes $1B net income by 2027 amid AI data center expansion, Q1 loss expected.

Applied Digital eyes $1B net income by 2027 amid AI data center expansion, Q1 loss expected.

Applied Digital is set to report a fiscal Q1 loss of $0.30 per share on $116.3 million revenue, reflecting ongoing investments in AI and high-performance data centers. The company has expanded its Polaris Forge 1 campus to 250 MW operational capacity...

Company Fundamentals
Bullish
29 minutes ago
Needham raises Vaxcyte price target after strong Phase 3 trial of VAX-31 vaccine

Needham raises Vaxcyte price target after strong Phase 3 trial of VAX-31 vaccine

Investment firm Needham increased its price target for Vaxcyte to $122 from $110 following positive Phase 3 trial results for Vaxcyte's VAX-31 pneumococcal vaccine. The vaccine met all primary endpoints in the OPUS-1 trial, showing noninferiority to ...

Analyst Insights
Bullish
1 hour ago
GMAB's Rina-S shows 45.9% response in ovarian cancer trial, advancing to Phase 3 studies.

GMAB's Rina-S shows 45.9% response in ovarian cancer trial, advancing to Phase 3 studies.

GMAB's investigational drug Rina-S demonstrated a 45.9% confirmed response rate in a Phase 1/2 trial for platinum-resistant ovarian cancer, with a median response duration of 12.1 months and median progression-free survival of 9.5 months. Despite ser...

Market News
Bullish
2 hours ago
NVIDIA price target raised to $345 on strong AI chip demand and earnings growth.

NVIDIA price target raised to $345 on strong AI chip demand and earnings growth.

BNP Paribas Exane raised NVIDIA's price target from $285 to $345 due to strong demand for its AI chips, signaling potential upside of about 45.6% from the current price. NVIDIA shares have gained about 25% in 2026, driven by growth in AI infrastructu...

Analyst Insights
Bullish
3 hours ago
Fidelity National Financial to report Q3 2026 earnings on Nov 5 with webcast and call on Nov 6

Fidelity National Financial to report Q3 2026 earnings on Nov 5 with webcast and call on Nov 6

Fidelity National Financial, a leading title insurance and insurance solutions provider, will release its third quarter 2026 earnings after market close on November 5, 2026. The company will hold a webcast and conference call at 11:00 a.m. Eastern Ti...

Company Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App